Domingo, 11 de octubre de 2026Apoyar

Aube.

Las noticias del progreso
LaboratorioFuente única

Lab study links PDIA4 to persistent osteoarthritis inflammation

Idiomas de este artículo
Original · ENFR

Texto original en inglés. 2 idiomas disponibles, el tuyo se añade con un clic.

A representative image from Liège shows an inflamed joint as a crowded map: fibroblasts, macrophages and lymphocytes sit alongside a yellow signal from stress-related proteins. In that tissue, researchers found that PDIA4 is not merely associated with osteoarthritis inflammation; laboratory experiments indicate that reducing it weakens the growth and movement of key joint cells.

The team examined the synovial membrane, the tissue lining the inside of a joint, in samples from patients with osteoarthritis, rheumatoid arthritis and other inflammatory arthropathies. They mapped 11 endoplasmic-reticulum stress proteins directly in human tissues. The endoplasmic reticulum is the cell’s production and quality-control system; prolonged stress leads cells to make chaperone proteins that help them keep functioning in difficult conditions.

Those proteins increased as inflammation progressed and clustered around fibroblast-like synoviocytes, or FLS — cells involved in remodeling tissue and contributing to joint damage. Zoé Gendebien, a researcher at the University of Liège’s Rheumatology Laboratory, said the proteins actively contribute to changes in the synovial membrane and to the persistence of inflammation.

PDIA4 was the clearest lead. When the researchers reduced its expression in laboratory experiments, FLS had their ability to proliferate and migrate significantly impaired, two processes involved in synovitis. The study, published in Cell Death & Differentiation, therefore offers a molecular target for future drug development, not evidence that an available medicine can block the disease.

So what changes in practical terms? Researchers may have a more specific handle on the cells that keep an inflamed joint active, potentially helping future therapies move beyond broadly suppressing inflammation. For patients, that possibility remains distant: the evidence currently stops at human tissue mapping and laboratory experiments, with no clinical trial or treatment result reported.

11Endoplasmic-reticulum stress proteins mapped in human joint tissues

Fuentes — leer los originales(hora de París)

Medical XpressEN
0000

Para leer a continuación

Comentarios

Cargando el hilo…

Inicia sesión para escribir un comentario. Iniciar sesión